(May 20, 2012) – A federal judge in Texas has dismissed failure-to-warn claims brought against makers of generic Reglan, ruling that they are preempted because the U.S. Food and Drug Administration approved the drug makers’...
Glaxo’s Anti-Seizure Drug Gets ‘Black-Box’ Warning on Eye Risks
Pharmaceutical giant, Glaxo-SmithKline’s anti-seizure drug, Potiga, now carries a black-box warning in the United States regarding risks that include potential loss of vision.
Black-box warnings are the most serious warnings issued by the U.S....
GranuFlo Lawsuits – Concealed Heart Attack Risks
Injured families and families of lost loved ones have filed lawsuits against Fresenius, the German-based manufacturer of GranuFlo and NaturaLyte, chemicals used in dialysis machines to help clean blood. The suit alleges that the chemicals...